Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome (Q46912071)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 November 2011

edit

Language	Label	Description	Also known as
English	Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome	scientific article published on 9 November 2011

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

title

Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

main subject

rituximab

1 reference

based on heuristic

inferred from title

author

Lutz Weber

series ordinal

10

object named as

Lutz Weber

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

author name string

Markus J Kemper

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

Jutta Gellermann

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

Sandra Habbig

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

Rafael T Krmar

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

Katalin Dittrich

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

Therese Jungraithmayr

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

Lars Pape

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

Ludwig Patzer

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

Heiko Billing

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

Martin Pohl

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

Katrin Rosenthal

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

Anne Rosahl

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

Dirk E Mueller-Wiefel

series ordinal

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

Jörg Dötsch

series ordinal

15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

language of work or name

English

0 references

publication date

9 November 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

published in

Nephrology Dialysis Transplantation

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

volume

27

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

page(s)

1910-1915

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

cites work

Management of childhood onset nephrotic syndrome.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Long-term outcome of children with steroid-sensitive idiopathic nephrotic syndrome.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Pathogenesis of lipoid nephrosis: a disorder of T-cell function

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Rituximab in refractory nephrotic syndrome.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Fatal pulmonary fibrosis after rituximab administration

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Rituximab: mechanism of action

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

retrieved

21 January 2018

Identifiers

DOI

10.1093/NDT/GFR548

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

PubMed publication ID

22076431

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22076431

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/22076431

ResearchGate publication ID

51792204

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46912071&oldid=2177545559"